XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2023
Stock-Based Compensation  
Stock-Based Compensation

(8)  Stock-Based Compensation

A summary of stock option activity for the nine months ended September 30, 2023 is as follows:

Weighted

Weighted

Average

Average

Exercise

Remaining

Price

Contractual

    

Shares

    

Per Share

    

Term (In Years)

Options outstanding at December 31, 2022

 

5,085,662

$

29.26

7.9

Granted

 

1,553,275

$

36.88

Exercised

 

(50,773)

$

15.89

Canceled

 

(180,580)

$

87.57

Options outstanding at September 30, 2023

 

6,407,584

$

29.57

7.8

Options vested and expected to vest at September 30, 2023

 

6,271,198

$

29.54

7.7

Options exercisable at September 30, 2023

 

3,088,826

$

29.58

6.6

Shares available for grant under the 2021 Plan

 

1,065,273

The weighted average grant-date fair value of stock options granted during the three and nine months ended September 30, 2023 was $25.80 and $28.38, respectively.

The aggregate intrinsic value of stock options vested and expected to vest at September 30, 2023 was $41.2 million. The aggregate intrinsic value of stock options exercisable at September 30, 2023 was $32.6 million. As of September 30, 2023, total compensation cost related to non-vested employee, consultant and non-employee director stock options not yet recognized was approximately $67.6 million, net of estimated forfeitures, which is expected to be recognized as expense over a weighted average period of 2.7 years.

Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 was recorded as follows:

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

(In thousands)

(In thousands)

Research and development

$

3,618

$

2,342

$

8,269

$

5,754

General and administrative

 

3,503

 

2,154

 

8,409

 

5,349

Total stock-based compensation expense

$

7,121

$

4,496

$

16,678

$

11,103

The fair values of employee, consultant and non-employee director stock options granted during the three and nine months ended September 30, 2023 and 2022 were valued using the Black-Scholes option pricing model with the following assumptions:

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

    

2023

    

2022

    

2023

    

2022

Expected stock price volatility

 

92%

91%

92%

90 – 97%

Expected option term

 

6.0 Years

6.0 Years

6.0 Years

6.0 Years

Risk-free interest rate

 

4.1%

2.9 – 3.5%

3.5 – 4.1%

1.7 – 3.6%

Expected dividend yield

 

None

None

None

None